Johnson & Johnson Partners With BARDA For COVID-19 Vaccine, Launches Lisa Ling Hosted Series

Johnson & Johnson recently announced a lead COVID-19 vaccine candidate plus a landmark partnership with BARDA. Together they commit over $1 billion to an investment to co-fund vaccine research, development & clinical testing.

A commitment by Johnson & Johnson was made to accelerated manufacturing plans as well. The company also introduced “The Road to a Vaccine,” a groundbreaking new series hosted by Lisa Ling.

The series explores the complex process of developing a COVID-19 vaccine and starts on April 14. Learn more here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s